Clinical Trial Update: Cetuximab and/or Bevacizumab Combined With Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer [Phase 3]

View source ↗

Summary

Phase 3 trial update evaluating cetuximab and/or bevacizumab with combination chemotherapy for metastatic colorectal cancer; results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Bevacizumab (bevacizumab)
• Cetuximab (cetuximab)

Snippet

Sponsor: Alliance for Clinical Trials in Oncology | Conditions: Colorectal Cancer | Phase 3 | Status: COMPLETED | Results posted: 2017-04-26